Off-label Prescription of Medication

被引:11
|
作者
Vrancken, Isabelle [1 ]
机构
[1] Univ Antwerp, Antwerp, Belgium
关键词
off-label use of medication; experimentation or therapy; informed consent; civil liability of the physician;
D O I
10.1163/15718093-12341352
中图分类号
D9 [法律]; DF [法律];
学科分类号
0301 ;
摘要
Off-label use of medication refers to prescribing a registered medicine outside its approved marketing authorization, purpose, target group, or indication. Off-label prescription is a widely accepted practice. However, no or little regulation can be found. In this article, the legal status of off-label prescription will be examined. Does off-label prescription fall under the therapeutical freedom and is it free from regulation? Or should we equalize off-label prescription with a therapeutical experimentation and should it follow the rules of experimentation? I will also examine whether the patient can give an informed consent. Whether or not this is possible leads to intense discussions. Finally, the potential liability of the prescribing physician is of great importance.
引用
收藏
页码:165 / 186
页数:22
相关论文
共 50 条
  • [21] Experts weigh in on promotion, prescription of off-label drugs
    Hampton, Tracy
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 297 (07): : 683 - 684
  • [22] A European proposal to regulate off-label prescription in China
    Vera Lúcia Raposo
    Asia Europe Journal, 2020, 18 : 511 - 527
  • [23] Drug users and antipsychotics: the role of off-label prescription
    Rossi, P.
    Martin Subero, M.
    Garcia Delgar, B.
    Fonseca Casals, F.
    Piatti, A. E.
    Torrens Melich, M.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2011, 21 : S596 - S597
  • [24] Off-Label Prescription of Drugs in the Statutory Health Insurance
    Niederauer, H. H.
    GESUNDHEITSWESEN, 2010, 72 (02) : 116 - 119
  • [25] Products liability and ''off-label'' uses of prescription drugs
    Stoffelmayr, KJ
    UNIVERSITY OF CHICAGO LAW REVIEW, 1996, 63 (01): : 275 - 306
  • [27] Off-Label Trazodone Prescription: Evidence, Benefits and Risks
    Bossini, Letizia
    Coluccia, Anna
    Casolaro, Ilaria
    Benbow, Jim
    Amodeo, Giovanni
    De Giorgi, Riccardo
    Fagiolini, Andrea
    CURRENT PHARMACEUTICAL DESIGN, 2015, 21 (23) : 3343 - 3351
  • [28] Patterns and predictors of off-label prescription of psychiatric drugs
    Vijay, Aishwarya
    Becker, Jessica E.
    Ross, Joseph S.
    PLOS ONE, 2018, 13 (07):
  • [29] A European proposal to regulate off-label prescription in China
    Raposo, Vera Lucia
    ASIA EUROPE JOURNAL, 2020, 18 (04) : 511 - 527
  • [30] Off-Label Promotion of Prescription Medicine: Is It Ever Justifiable?
    Ghinea, Narcyz
    Lipworth, Wendy
    Kerridge, Ian
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2015, 49 (03) : 359 - 363